John E. Kao - Nov 1, 2022 Form 4 Insider Report for Alignment Healthcare, Inc. (ALHC)

Role
Chief Executive Officer, Director
Signature
/s/ Richard A. Cross, as Attorney-in-Fact, for John E. Kao
Stock symbol
ALHC
Transactions as of
Nov 1, 2022
Transactions value $
-$330,830
Form type
4
Date filed
11/2/2022, 04:25 PM
Previous filing
Oct 28, 2022
Next filing
Dec 2, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALHC Common Stock Sale -$331K -25K -0.9% $13.23 2.75M Nov 1, 2022 See Footnote F1, F2, F3
holding ALHC Common Stock 2.42M Nov 1, 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person.
F2 The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $13.08 to $13.38. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.
F3 Represents securities held by JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee.